医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Firstsource Positioned as a ‘Leader’ and a ‘Star Performer’ in Everest Group Healthcare Payer Operations PEAK Matrix® Assessment 2023

2023年10月05日 PM10:03
このエントリーをはてなブックマークに追加


 

MUMBAI, India & LOUISVILLE, Ky.

Firstsource Solutions Limited (NSE: FSL, BSE:532809), a global provider of Business Process Management (BPM) services and an RP-Sanjiv Goenka Group company, was positioned as a ‘Leader’ and a ‘Star Performer’ in Everest Group Healthcare Payer Operations PEAK Matrix® Assessment 2023.

The Healthcare Payer Operations PEAK Matrix® assessed 29 service providers’ overall vision, capability and market impact, classifying Firstsource among nine payer operations as a ‘Leader’, and one of only two as a ‘Star Performer’ for demonstrating the strongest forward and upward movement in 2022 on the PEAK Matrix®.

Venkatgiri Vandali, Chief Sales Transformation Officer, and President – Healthcare and Lifesciences at Firstsource shares, “This is an incredible recognition of the quality of our services, our investment strategy, and the value we bring to our clients. Our digital-first ethos has enabled a strong focus on building innovative digital and tech solutions that create efficiencies for our clients and deliver a superior and personalized member experience. With claims management and member engagement a key and competitive space, our strong digital health solutions portfolio and ability to scale are poised to further propel our growth and success in the market.”

Firstsource’s Healthcare Payer Operations scored high across all parameters, particularly on considerations of portfolio mix, scope of services offered, and delivery footprint. Calling out Firstsource’s strengths, the report highlighted the proactive investments made by the company toward solutions that cater to the demands of the market, such as the solution built by the company to help clients address Medicaid redetermination and support members through the renewal process. The report also emphasized the investments made by Firstsource in digital solutions and technologies like process mining, AI claims processing, and AI/ML-driven personalized engagement platforms to support the digital transformation journey for clients.

“The healthcare industry is rapidly shifting towards value-based care, driving health plan enterprises to embrace cutting-edge AI solutions for core administrative processes. This has led to increased demand for third-party support to boost innovation and ensure member satisfaction,” said Ankur Verma, Vice President at Everest Group. “Firstsource, with its digital-first approach, offers a large set of proprietary solutions backed by strategic partnerships. Moreover, its investments in forward looking initiatives such as a Medicaid redetermination solution, AI enabled platforms and expansion of delivery capabilities to meet the demands of a growing client base have led to its positioning as a Leader and a Star Performer on Everest Group’s Healthcare Payer Operations PEAK Matrix Assessment 2023.”

About Firstsource

Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL, BSE: 532809, Reuters: FISO.BO, Bloomberg: FSOL:IN), is a leading provider of transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, and other industries. The Company’s ‘Digital First, Digital Now’ approach helps organizations reinvent operations and reimagine business models, enabling them to deliver moments that matter and build competitive advantage. With an established presence in the US, the UK, Mexico, India, and the Philippines, Firstsource acts as a trusted growth partner for over 150 leading global brands, including several Fortune 500 and FTSE 100 companies. (www.firstsource.com)

View source version on businesswire.com: https://www.businesswire.com/news/home/20231005313817/en/

CONTACT

Media

Madhavi Behl

Firstsource Solutions

madhavi.behl@firstsource.com

Anisa Lacey

Aria Marketing for Firstsource

alacey@ariamarketing.com

901-618-6077

同じカテゴリーの記事 

  • Kolmar BNH, a Top-Tier Korean Enterprise Specializing in the Production of HemoHIM, Dedicates over 2% of its Annual Sales to R&D
  • Takeda公布2023财年全年业绩和2024财年展望,确认对后期研发管线开发和提高核心营业利润率的承诺
  • Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
  • AMLにおける寛解期に残存するFLT3-ITD変異と移植後の転帰との間に重要な関連があることが研究によって判明
  • 研究表明AML缓解期残留FLT3-ITD突变与移植后结果之间存在重要联系